Detection of male DNA in the liver of female patients with primary biliary cirrhosis

Journal of Hepatology

Volumn 33, Issue 5, 2000, Pages 690-695

  Fanning, Peter A ^a   Jonsson, Julie R ^b   Clouston, Andrew D ^a   Edwards Smith, Cathy ^b   Balderson, Glenda A ^b   Macdonald, Graeme A ^c,d   Crawford, Darrell H G ^a   Kerlin, Paul ^a   Powell, Lawrie W ^d   Powell, Elizabeth E ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b University Department of Surgery   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Autoimmune disease; Fetal cell; Microchimerism; Pregnancy

Indexed keywords

DNA;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE DISEASE; BILE DUCT; BILIARY CIRRHOSIS; CHOLESTASIS; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; FETUS CELL; GRAFT VERSUS HOST REACTION; HUMAN; IN SITU HYBRIDIZATION; LIVER BIOPSY; LIVER FIBROSIS; MICROCHIMERISM; MONONUCLEAR CELL; MONONUCLEAR PHAGOCYTE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; Y CHROMOSOME;

EID: 0033763832     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80297-4     Document Type: Article

References (29)

1. Primary biliary cirrhosis
2. Autoimmune associations in primary biliary cirrhosis
3. Chronic graft-versus-host disease and primary biliary cirrhosis: Sorting the puzzle pieces
4. Maternal-fetal immunology and autoimmune disease
5. Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy
6. Male fetal progenitor cells persist in maternal blood for as long as 27 years post-partum
7. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma
8. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis
9. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma
10. Peripheral blood chimerism following human liver transplantation
11. Role of donor leukocyte chimerism in establishing the etiology of neutropenia following liver transplantation
12. Immune diseases of the liver and bile duct
13. Antimitochondrial antibodies in patients with chronic graft-versus-host disease
14. Hepatic lesion in murine chronic graft-versus-host disease to minor histocompatibility antigens. A reproducible model of nonsuppurative destructive cholangitis
15. FISH for Y chromosome in women with primary biliary cirrhosis: Lack of evidence for leukocyte microchimerism
16. Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis
17. Dendritic cells: Unique leukocyte populations which control the primary immune response
18. S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis?
19. Primary biliary cirrhosis (PBC): Antigen-presenting cells differ in their distribution in early and late stage PBC and involve the ductal but not the ductular compartment
20. Dendritic cells in portal tracts in chronic hepatitis C and primary biliary cirrhosis with relevance to bile duct damage: An immunohistochemical study
21. Lymphoid dendritic cells in the liver of patients with primary biliary cirrhosis and its mouse model
22. Two-way cell traffic between mother and fetus: Biologic and clinical implication
23. Microchimerism of maternal origin persists into adult life
24. HLA homozygosity and the risk of related-donor transfusion-associated graft versus-host disease
25. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation
26. Anti-NK antibodies injected into recipient mice enhance engraftment and chimerism after allogeneic transplantation of fetal liver stem cells
27. Natural killer-cell activity and the response to interferons alpha, beta, and gamma in patients with primary biliary cirrhosis
28. Abnormal natural killer cytotoxicity in primary biliary cirrhosis: Evidence for a functional deficiency of cytolytic effector cells
29. Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis